Predicting the treatment effect of sorafenib using serum angiogenesis markers in patients with hepatocellular carcinomaKoji Miyahara, Kazuhide Yamamoto, Kazuhiro Nouso et al.|Journal of Gastroenterology and Hepatology|2011Cited by 90
Clinical utility of high-throughput glycome analysis in patients with pancreatic cancerKazuhiro Nouso, Kazuhide Yamamoto, Maho Amano et al.|Journal of Gastroenterology|2013Cited by 54
Prognotic impact of serum follistatin in patients with hepatocellular carcinomaTakeshi Tomoda, Kazuhide Yamamoto, Kazuhiro Nouso et al.|Journal of Gastroenterology and Hepatology|2013Cited by 22
Clinical utility of serum fucosylated hemopexin in Japanese patients with hepatocellular carcinomaSayo Kobayashi, Kazuhide Yamamoto, Kazuhiro Nouso et al.|Hepatology Research|2012Cited by 20
Plasma KRAS mutations predict the early recurrence after surgical resection of pancreatic cancerSoichiro Ako, Hiroyuki Okada, Takeshi Tomoda et al.|Cancer Biology & Therapy|2021Cited by 18